ATE219372T1 - Verfahren zur behandlung von blutungsstorungen - Google Patents
Verfahren zur behandlung von blutungsstorungenInfo
- Publication number
- ATE219372T1 ATE219372T1 AT95917218T AT95917218T ATE219372T1 AT E219372 T1 ATE219372 T1 AT E219372T1 AT 95917218 T AT95917218 T AT 95917218T AT 95917218 T AT95917218 T AT 95917218T AT E219372 T1 ATE219372 T1 AT E219372T1
- Authority
- AT
- Austria
- Prior art keywords
- treating
- vwd
- bleeding disorders
- von willebrand
- congenital
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000000740 bleeding effect Effects 0.000 title abstract 2
- 208000027276 Von Willebrand disease Diseases 0.000 abstract 4
- 208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 abstract 4
- 206010010356 Congenital anomaly Diseases 0.000 abstract 2
- 208000037157 Azotemia Diseases 0.000 abstract 1
- 102100026735 Coagulation factor VIII Human genes 0.000 abstract 1
- 201000003542 Factor VIII deficiency Diseases 0.000 abstract 1
- 206010016654 Fibrosis Diseases 0.000 abstract 1
- 208000009292 Hemophilia A Diseases 0.000 abstract 1
- 208000032843 Hemorrhage Diseases 0.000 abstract 1
- 208000024659 Hemostatic disease Diseases 0.000 abstract 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 1
- 230000007882 cirrhosis Effects 0.000 abstract 1
- 208000019425 cirrhosis of liver Diseases 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 208000031169 hemorrhagic disease Diseases 0.000 abstract 1
- 208000004521 platelet storage pool deficiency Diseases 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 208000009852 uremia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2073—IL-11
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Soy Sauces And Products Related Thereto (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/278,765 US5582821A (en) | 1994-07-22 | 1994-07-22 | Methods for treating bleeding disorders |
| PCT/US1995/005439 WO1996003143A1 (en) | 1994-07-22 | 1995-04-27 | Methods for treating bleeding disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE219372T1 true ATE219372T1 (de) | 2002-07-15 |
Family
ID=23066267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95917218T ATE219372T1 (de) | 1994-07-22 | 1995-04-27 | Verfahren zur behandlung von blutungsstorungen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5582821A (de) |
| EP (1) | EP0772450B1 (de) |
| JP (1) | JPH10503195A (de) |
| AT (1) | ATE219372T1 (de) |
| AU (1) | AU2381795A (de) |
| DE (1) | DE69527145T2 (de) |
| DK (1) | DK0772450T3 (de) |
| ES (1) | ES2177646T3 (de) |
| PT (1) | PT772450E (de) |
| WO (1) | WO1996003143A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO439396A0 (en) | 1996-12-24 | 1997-01-23 | Walter And Eliza Hall Institute Of Medical Research, The | A method of treatment and prophylaxis |
| US6953777B2 (en) | 1999-03-11 | 2005-10-11 | Genetics Indtitute LLC | Use of interleukin-11 to prevent immune-mediated cytotoxicity |
| NZ516664A (en) * | 1999-07-15 | 2003-06-30 | Inst Genetics Llc | Formulations and compositions for interleukin-11 |
| AU2002362088A1 (en) * | 2001-12-06 | 2003-06-23 | Catholic University | Method and composition for inducing weight loss |
| US9788539B2 (en) | 2011-05-17 | 2017-10-17 | Velico Medical, Inc. | Platelet protection solution having beta-galactosidase and sialidase inhibitors |
| AU2012255137A1 (en) | 2011-05-17 | 2013-12-12 | The Brigham And Women's Hospital, Inc. | Improved platelet storage using a sialidase inhibitor |
| EP2903430A1 (de) | 2012-10-05 | 2015-08-12 | Velico Medical, Inc. | Plättchenadditivlösung mit beta-galactosidase-inhibitor |
| WO2014120886A1 (en) | 2013-01-30 | 2014-08-07 | Velico Medical, Inc. | Platelet additive solution having a self-assembling hydrogel-forming peptide |
| US20150160214A1 (en) * | 2013-12-05 | 2015-06-11 | Mayo Foundation For Medical Education And Research | Quantitation of Cellular Adhesion Dynamics Across Immobilized Receptors Under Rheological Shear Flow |
| CA3211686A1 (en) | 2021-02-26 | 2022-09-01 | Bayer Aktiengesellschaft | Inhibitors of il-11 or il-11ra for use in the treatment of abnormal uterine bleeding |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4518584A (en) * | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
| US5215895A (en) * | 1989-11-22 | 1993-06-01 | Genetics Institute, Inc. | Dna encoding a mammalian cytokine, interleukin-11 |
| DK0546124T4 (da) * | 1990-08-29 | 2003-05-19 | Inst Genetics Llc | Hæmatopoiese-stimulatorer med flere domæner |
| US5270181A (en) * | 1991-02-06 | 1993-12-14 | Genetics Institute, Inc. | Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| US5292646A (en) * | 1991-02-06 | 1994-03-08 | Genetics Institute, Inc. | Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| EP0560998A4 (en) * | 1991-10-09 | 1993-12-01 | Toray Industries, Inc. | Medicine for preventing and treating bleeding tendency |
-
1994
- 1994-07-22 US US08/278,765 patent/US5582821A/en not_active Expired - Lifetime
-
1995
- 1995-04-27 ES ES95917218T patent/ES2177646T3/es not_active Expired - Lifetime
- 1995-04-27 DE DE69527145T patent/DE69527145T2/de not_active Expired - Fee Related
- 1995-04-27 JP JP8505717A patent/JPH10503195A/ja active Pending
- 1995-04-27 PT PT95917218T patent/PT772450E/pt unknown
- 1995-04-27 EP EP95917218A patent/EP0772450B1/de not_active Expired - Lifetime
- 1995-04-27 WO PCT/US1995/005439 patent/WO1996003143A1/en not_active Ceased
- 1995-04-27 DK DK95917218T patent/DK0772450T3/da active
- 1995-04-27 AU AU23817/95A patent/AU2381795A/en not_active Abandoned
- 1995-04-27 AT AT95917218T patent/ATE219372T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US5582821A (en) | 1996-12-10 |
| EP0772450B1 (de) | 2002-06-19 |
| EP0772450A1 (de) | 1997-05-14 |
| JPH10503195A (ja) | 1998-03-24 |
| DK0772450T3 (da) | 2003-04-14 |
| PT772450E (pt) | 2002-10-31 |
| ES2177646T3 (es) | 2002-12-16 |
| DE69527145T2 (de) | 2003-02-13 |
| WO1996003143A1 (en) | 1996-02-08 |
| DE69527145D1 (de) | 2002-07-25 |
| AU2381795A (en) | 1996-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE66374T1 (de) | Zubereitungen und verfahren zur behandlung von blutungsstoerungen. | |
| DE69625691D1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
| DE69428905D1 (de) | Aktivierter faktor viii als ein therapeutisches mittel und verfahren zur behandlung eines faktor viii mangels | |
| DE69535264D1 (de) | Verfahren zur behandlung von diabetes mittels kgf | |
| DE69521623D1 (de) | Zusammensetzung für die stabilisation von zahnprothesen | |
| RU94032284A (ru) | Карбоксамиды, способ их получения, фармацевтическая композиция, применение | |
| DE69333286D1 (de) | Eine thrombin-blutfraktion zur verwendung in einem medizinischen verfahren | |
| EA199800620A1 (ru) | Замещенные n-[(аминоиминометил или аминометил)фенил] пропиламиды | |
| DE59407237D1 (de) | Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems | |
| ATE232093T1 (de) | Verwendung von fumarsäurederivaten zur behandlung von autoimmunerkrankungen | |
| ATE225176T1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
| DE69521700D1 (de) | Mittel und methoden zur behandlung von plaque-krankheiten | |
| ATE22657T1 (de) | Prostaglandin e1, enthaltende emulsion und verfahren zu ihrer herstellung. | |
| DE69214610D1 (de) | Verfahren zur Behandlung von Erdgas | |
| DE69631605D1 (de) | Verfahren zur verringerung und zur erhaltung von verringerten blutspiegeln von lipiden mittels zubereitungen von ob-proteinen | |
| DE69527145D1 (de) | Verfahren zur behandlung von blutungsstorungen | |
| EA199800690A1 (ru) | Замещенные n-[(аминоиминометил)фенилалкил]азагетероцикламиды сульфоновых кислот | |
| DE69029100D1 (de) | Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris | |
| NO995843D0 (no) | Farmasöytisk preparat omfattende vWF-propeptid | |
| DE60035693D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
| ATE25690T1 (de) | Gerinnungsaktive plasmaproteinloesung, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von stoerungen des haemostasesystems. | |
| ATE321045T1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
| DE69327314D1 (de) | Zusammensetzungen enthaltend Lipoprotein-Associated-Coagulation-Inhibitor (LACI) zur Herstellung eines Medikaments zur Behandlung von akuten oder chronischen Enzündungen | |
| ATE430578T1 (de) | Faktor viii oder von willebrand faktor zur behandlung von thrombopathie assoziierenden hämorrhagischen erkrankungen | |
| ATE114468T1 (de) | Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0772450 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |